|
1
|
Preexposure prophylaxis for HIV infection among African women.
|
N Engl J Med
|
2012
|
15.28
|
|
2
|
Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.
|
Lancet
|
2008
|
7.93
|
|
3
|
Assessing the reporting of adherence and sexual activity in a simulated microbicide trial in South Africa: an interview mode experiment using a placebo gel.
|
AIDS Behav
|
2011
|
1.68
|
|
4
|
Hormonal contraception and the risk of HIV acquisition among women in South Africa.
|
AIDS
|
2012
|
1.41
|
|
5
|
FEM-PrEP: adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis.
|
J Acquir Immune Defic Syndr
|
2014
|
1.36
|
|
6
|
The science of being a study participant: FEM-PrEP participants' explanations for overreporting adherence to the study pills and for the whereabouts of unused pills.
|
J Acquir Immune Defic Syndr
|
2015
|
1.10
|
|
7
|
Drug resistance and plasma viral RNA level after ineffective use of oral pre-exposure prophylaxis in women.
|
AIDS
|
2015
|
1.10
|
|
8
|
The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection.
|
Antivir Ther
|
2011
|
0.98
|
|
9
|
Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP.
|
J Acquir Immune Defic Syndr
|
2014
|
0.94
|
|
10
|
Participants' Explanations for Nonadherence in the FEM-PrEP Clinical Trial.
|
J Acquir Immune Defic Syndr
|
2016
|
0.87
|
|
11
|
Risks in the use of an unblinded-control group.
|
J Infect Dis
|
2005
|
0.75
|
|
12
|
Enrolling adolescents in research on HIV: young women must be included.
|
PLoS Med
|
2006
|
0.75
|
|
13
|
To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.
|
Cult Health Sex
|
2015
|
0.75
|